A new system to approve medicines faster has been introduced. But barriers to RSV protections show why that’s only one step in getting them to patients.
Articles on Medicine regulation
Displaying all articles
Aggressive and misleading marketing is fuelling demand for medicinal cannabis. Here are some of the ways clinics bend the rules.
Australia is still aiming to start vaccinating high-risk groups from March. Why the delay?
The UK government is allowing care homes and hospices to reuse leftover medicines during the pandemic. Here’s why that’s a good thing.
Medical cannabis challenges scientific norms and the usual regulation of medicines.
Top contributors
-
Professor in Substance Use, Liverpool John Moores University
-
Professor of Computer and Human Interaction, University of Reading
-
Postdoctoral research associate, University of Reading
-
Professor of Biosensors, University of Reading
-
Professor in Pharmaceutical Policy, School of Pharmacy and Charles Perkins Centre, University of Sydney
-
Associate professor, Department of Family and Community Medicine, University of Toronto; York University, Canada; University of Sydney
-
Honorary Lecturer, School of Pharmacy, Charles Perkins Centre, University of Sydney
-
University of Oxford
-
Associate Lecturer, School of Pharmacy and Charles Perkins Centre, University of Sydney
-
Emeritus Professor, National Centre for Youth Substance Use Research, The University of Queensland
-
NHMRC Emerging Leadership Fellow, National Centre for Youth Substance Use Research, The University of Queensland
-
Research Fellow, Faculty of Education, Health, and Psychological Sciences, Te Herenga Waka — Victoria University of Wellington; Flinders University; The University of Melbourne